GENE ONLINE|News &
Opinion
Blog

2026-02-04|

Regal Rexnord Reports $735 Million in Data Center Orders and Organic Growth Acceleration in Q4 2025

by GOAI
Share To

Regal Rexnord Corporation released its financial results for the fourth quarter of 2025, reporting significant organic growth acceleration and securing approximately $735 million in data center orders. The company highlighted strong performance across its business segments, attributing the growth to increased demand and strategic initiatives implemented during the year.

The report detailed that Regal Rexnord experienced robust financial outcomes in Q4 2025, with notable contributions from its data center segment. The company confirmed that it secured substantial orders valued at around $735 million within this sector, reflecting heightened activity and investment in data infrastructure. Additionally, the corporation emphasized organic growth as a key driver of its quarterly success, indicating improved operational efficiency and market responsiveness. Further specifics on revenue figures or profit margins were not disclosed in the announcement.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: February 4, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
NorthWestern Energy Reports $1.4 Billion Revenue and $150 Million Net Income for 2025
2026-02-11
Nissay Asset Management Corporation Becomes First in Japan to Implement Broadridge’s MBS Trade Assignment Portal
2026-02-11
Ballard Power Systems Schedules February 12, 2026 Conference Call to Discuss 2025 Financial Results
2026-02-11
Zeus North America Mining Corp. Adjusts Private Placement Unit Price to $0.05
2026-02-11
February 2026 Review Questions Shareholder Deal Fairness at MCFT, SLAB, and MPX
2026-02-11
Questions Arise Over Shareholder Value in Financial Decisions by Nathan’s Famous, SkyWater Technology, and Gold Resource Corporation
2026-02-11
Pivekimab Sunirine Shows Promise as First-Line Treatment in BPDCN Clinical Trial
2026-02-11
EVENT
2026-02-09
World Health Expo Dubai
Dubai Exhibition Centre, Dubai
2026-02-17
BIO Asia 2026 (Life Science Partnerships)
Hyderabad, India
2026-02-24
Rare Disease Week on Capitol Hill (Policy and Advocacy)
Capitol Hill, Washington, D.C.
2026-03-09
HIMSS26 (Digital Health & Hospital IT)
Las Vegas, Nevada
2026-03-23
DCAT Week
New York, USA
Scroll to Top